bold-100
spdr s&p biotech,bold therap,ishares biotechnology,intezyne
['bold-100', 'gastric', 'bold-100 ', '$ibb', '$xbi', 'bold thera']
bold therapeutics presents promising interim phase 2 results for bold-100 in advanced gastric and biliary tract cancer at asco 2023 more info: $xbi $ibb $xph $pph 
BioPharma/Biotech Intel.  Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  http://globalclinicalt